Tackling access and payer barriers for growth hormone therapy in Saudi Arabia: a consensus statement for the Saudi Working Group for Pediatric Endocrinology

被引:0
作者
Attia, Najya [1 ,2 ,3 ]
Moussa, Khairya [4 ]
Altwaim, Abdulaziz [5 ,6 ]
Al-Agha, Abdulmoein Eid [7 ]
Amir, Ashraf A. [8 ]
Almuhareb, Aseel [9 ]
机构
[1] King Saud binAbdulaziz Univ Hlth Sci, Dept Pediat, Mail Code 6325, Jeddah 21423, Saudi Arabia
[2] King Abdul Aziz Med City, Natl Guard Hlth Affairs, POB 9515, Jeddah 21423, Saudi Arabia
[3] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Dept Pediat Endocrinol, King Abdulaziz Med City, Jeddah, Saudi Arabia
[4] Andalusia Med Grp, Jeddah, Saudi Arabia
[5] King Saud bin Abdulaziz Univ Hlth Sci KSAU HS, Riyadh, Saudi Arabia
[6] Int Diabet Care Ctr, Jeddah, Saudi Arabia
[7] King Abdulaziz Univ Hosp, Pediat Dept, Pediat Endocrinol & Diabet Sect, Jeddah, Saudi Arabia
[8] Int Med Ctr, Jeddah, Saudi Arabia
[9] Pfizer, Riyadh, Saudi Arabia
关键词
barriers; growth hormone; short stature; payer; access; Saudi Arabia; IDIOPATHIC SHORT STATURE; FOR-GESTATIONAL-AGE; LONG-TERM SAFETY; GH DEFICIENCY; FACTOR-I; IGF-I; BINDING PROTEIN-3; JAPANESE CHILDREN; DIAGNOSTIC-VALUE; REFERENCE VALUES;
D O I
10.1515/jpem-2024-0021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prompt diagnosis and early treatment are key goals to optimize the outcomes of children with growth hormone deficiency (GHD) and attain the genetically expected adult height. Nonetheless, several barriers can hinder prompt diagnosis and treatment of GHD, including payer-related issues. In Saudi Arabia, moderate-to-severe short stature was reported in 13.1 and 11.7 % of healthy boys and girls, respectively. Several access and payer barriers can face pediatric endocrinologists during the diagnosis and treatment of GHD in Saudi Arabia. Insurance coverage policies can restrict access to diagnostic tests for GHD and recombinant human growth hormone (rhGH) due to their high costs and lack of gold-standard criteria. Some insurance policies may limit the duration of treatment with rhGH or the amount of medication covered per month. This consensus article gathered the insights of pediatric endocrinologists from Saudi Arabia to reflect the access and payer barriers to the diagnostic tests and treatment options of children with short stature. We also discussed the current payer-related challenges endocrinologists face during the investigations of children with short stature. The consensus identified potential strategies to overcome these challenges and optimize patient management.
引用
收藏
页码:387 / 399
页数:13
相关论文
共 118 条
[1]   HEALTH-INSURANCE AND UTILIZATION OF MEDICAL-CARE FOR CHILDREN WITH SPECIAL HEALTH-CARE NEEDS [J].
ADAY, LA ;
LEE, ES ;
SPEARS, B ;
CHUNG, CW ;
YOUSSEF, A ;
BLOOM, B .
MEDICAL CARE, 1993, 31 (11) :1013-1026
[2]   Is growth hormone deficiency associated with anxiety disorder and depressive symptoms in children and adolescents?: A case-control study [J].
Akaltun, Ismail ;
Cayir, Atilla ;
Kara, Tayfun ;
Ayaydin, Hamza .
GROWTH HORMONE & IGF RESEARCH, 2018, 41 :23-27
[3]  
Al Herbish Abdullah S, 2016, Int J Pediatr Adolesc Med, V3, P91, DOI [10.1016/j.ijpam.2016.07.002, 10.1016/j.ijpam.2016.07.002]
[4]   Growth hormone therapy and treatment outcomes: current clinical practice of the Gulf Cooperation Council [J].
Al Herbish, Abdullah S. ;
Al Alwan, Ibrahim ;
Al Mutair, Angham ;
Al Twaim, Abdulaziz ;
Al Agha, Abdul-Moein ;
Deeb, Asma ;
Abdul-Rasoul, Majedah ;
El-Awwa, Ahmed ;
Al Mushcab, Suzan ;
Esmat, Khaled .
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (04) :319-325
[5]   The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study [J].
Al Khalifah, Reem Abdullah ;
Alhakami, Amal ;
AlRuthia, Yazed ;
Al Sarraj, Hadeel Zohair ;
Abulqasim, Jumana ;
Al-Rasheedi, Ameinah ;
NurHussen, Akram ;
Naji, Ammar .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 35 (11) :1357-1368
[6]   Dose-Dependent Effect of Growth Hormone on Final Height in Children with Short Stature without Growth Hormone Deficiency [J].
Albertsson-Wikland, Kerstin ;
Aronson, A. Stefan ;
Gustafsson, Jan ;
Hagenas, Lars ;
Ivarsson, Sten A. ;
Jonsson, Bjorn ;
Kristrom, Berit ;
Marcus, Claude ;
Nilsson, Karl Olof ;
Ritzen, E. Martin ;
Tuvemo, Torsten ;
Westphal, Otto ;
Aman, Jan .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (11) :4342-4350
[7]   NATURAL GROWTH IN CHILDREN BORN SMALL-FOR-GESTATIONAL-AGE WITH AND WITHOUT CATCH-UP GROWTH [J].
ALBERTSSONWIKLAND, K ;
KARLBERG, J .
ACTA PAEDIATRICA, 1994, 83 :64-71
[8]   The Association Between Wait Times and Patient Satisfaction: Findings From Primary Health Centers in the Kingdom of Saudi Arabia [J].
Alrasheedi, Khaled Falah ;
AL-Mohaithef, Mohammed ;
Edrees, Hanan H. ;
Chandramohan, Sriram .
HEALTH SERVICES RESEARCH AND MANAGERIAL EPIDEMIOLOGY, 2019, 6
[9]   Growth hormone treatment in young children with Down's syndrome:: effects on growth and psychomotor development [J].
Annerén, G ;
Tuvemo, T ;
Carlsson-Skwirut, C ;
Lönnerholm, T ;
Bang, P ;
Sara, VR ;
Gustafsson, J .
ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (04) :334-338
[10]   Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation [J].
不详 .
HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (42) :1-+